drugset / Trial / NCT00488761
Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI
RandomizedSingle-groupOpen-labelTreatment
Summary
Tigecycline's activity against resistant organisms, as well as significant coverage of both gram-positive and gram-negative bacteria, may provide a valuable therapeutic alternative in treating patients with complicated skin and/or skin structure infections.
Timeline
- Start
- 2006-07
- Primary completion
- —
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tigecycline | Small molecule | — | — |